IC7 Stock Overview
Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
ICU Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$124.00 |
| 52 Week High | US$170.00 |
| 52 Week Low | US$92.50 |
| Beta | 0.88 |
| 1 Month Change | 0.81% |
| 3 Month Change | -18.95% |
| 1 Year Change | 30.53% |
| 3 Year Change | -27.49% |
| 5 Year Change | -28.74% |
| Change since IPO | 365.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| IC7 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.8% | 0.8% | 0.8% |
| 1Y | 30.5% | -9.3% | 15.0% |
Return vs Industry: IC7 exceeded the German Medical Equipment industry which returned -9% over the past year.
Return vs Market: IC7 exceeded the German Market which returned 14.4% over the past year.
Price Volatility
| IC7 volatility | |
|---|---|
| IC7 Average Weekly Movement | 9.7% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: IC7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: IC7's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 15,000 | Vivek Jain | www.icumed.com |
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
ICU Medical, Inc. Fundamentals Summary
| IC7 fundamental statistics | |
|---|---|
| Market cap | €3.10b |
| Earnings (TTM) | -€83.36m |
| Revenue (TTM) | €2.15b |
Is IC7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IC7 income statement (TTM) | |
|---|---|
| Revenue | US$2.42b |
| Cost of Revenue | US$1.57b |
| Gross Profit | US$849.65m |
| Other Expenses | US$943.34m |
| Earnings | -US$93.69m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.81 |
| Gross Margin | 35.11% |
| Net Profit Margin | -3.87% |
| Debt/Equity Ratio | 77.3% |
How did IC7 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 11:35 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ICU Medical, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Terwilliger | Benchmark Company |
| Lawrence Solow | CJS Securities, Inc. |
| Jeffrey Cohen | C. K. Cooper & Company, Inc. |